Chapman Investment Management’s Idexx Laboratories IDXX Stock Holding History

Chapman Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,824	Closed	-$4.83M	–	44
2022 Q1	$4.83M	Hold	8,824	–	–	2.57%	15
2021 Q4	$5.81M	Hold	8,824	–	–	2.66%	16
2021 Q3	$5.49M	Sell	8,824 -17	-0.2%	-$11.4K	2.85%	18
2021 Q2	$5.58M	Hold	8,841	–	–	3.1%	15
2021 Q1	$4.33M	Sell	8,841 -27	-0.3%	-$13.5K	2.73%	19
2020 Q4	$4.43M	Hold	8,868	–	–	2.88%	19
2020 Q3	$3.49M	Buy	8,868 +17	+0.2%	+$6.29K	2.58%	18
2020 Q2	$2.92M	Hold	8,851	–	–	2.39%	18
2020 Q1	$2.14M	Sell	8,851 -412	-4%	-$108K	2.29%	17
2019 Q4	$2.42M	Buy	+9,263	New	+$2.44M	2.21%	20

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Chapman Investment Management's IDXX Position: Q2 2022 in Review

Chapman Investment Management sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 8,824 shares — an estimated $4.83M sold.

Chapman Investment Management first reported a position in IDXX in Q4 2019 and held it in 10 quarters. The position peaked at $5.81M in Q4 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

Chapman Investment Management reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
Chapman Investment Management sold 8,824 Idexx Laboratories shares in Q2 2022, an estimated $4.83M.
Chapman Investment Management first reported a position in Idexx Laboratories in Q4 2019 and held it in 10 quarters.
Chapman Investment Management's Idexx Laboratories position peaked at $5.81M in Q4 2021.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Chapman Investment Management's 13F filing for Q2 2022, filed 1 Aug 2022.